A carregar...
Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
These days, the use of biosimilars for the treatment of bio-naive patients is well established. However, the transition of patients being treated with a bio-originator to its biosimilar is still a topic of discussion. The main issue is which approach to use when initiating the non-medical transition...
Na minha lista:
| Publicado no: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Mediterranean Journal of Rheumatology (MJR)
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280871/ https://ncbi.nlm.nih.gov/pubmed/32524082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.30.1.76 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|